Navigation Links
Kosan Opens TIME-1 Pivotal Phase 3 Trial in Multiple Myeloma
Date:1/3/2008

Kosan Leads Industry with Most Advanced Hsp90 Inhibitor in Clinical

Development New Supportive Trial in Less Refractory Patients to Replace Current TIME-2

Trial

Conference Call and Webcast Today

HAYWARD, Calif., Jan. 3 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN) today announced that the Tanespimycin in Myeloma Evaluation or TIME-1 pivotal Phase 3 trial for tanespimycin as a potential treatment for multiple myeloma is open for enrollment. TIME-1 is a pivotal Phase 3 trial comparing tanespimycin in combination with bortezomib (Velcade(R)) with bortezomib alone in patients following a single prior course of treatment (first-relapse). Kosan has completed both a Special Protocol Assessment with the U.S. Food and Drug Administration and a Scientific Advice process with the Committee for Medicinal Products for Human Use of the centralized European Medicines Agency, thus, providing what the company believes is a validated path to registration in many major world markets for the TIME-1 trial. TIME-1 is the most advanced Hsp90 inhibitor clinical program in the industry, underscoring the company's leadership in this new class of anticancer therapies.

The TIME registration program is designed to include two trials: a pivotal Phase 3 trial (TIME-1) and a smaller supportive trial. The TIME-1 trial is proceeding on track and remains the foundation of the company's registration strategy. The TIME-2 trial, recently opened for patients who have failed numerous (at least three) prior myeloma therapies, will be closed and replaced with an alternative supportive trial. TIME-2 had been designed to support TIME-1 for full appr
'/>"/>

SOURCE Kosan Biosciences Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Kosan Announces November 8, 2007 Conference Call and Webcast of Third Quarter 2007 Financial Results
2. Seabrook House Opens Transitional Living Facility: Seabrook West
3. New Web Site Opens Window on Charges, Payments, Quality of Care at Michigan Hospitals
4. NBA Legend Dikembe Mutombo Joins Opportunity International Board of Advisors; Opens Doors in Democratic Republic of Congo
5. EndoGastric Solutions Opens Three Training Centers to Keep Up with Demand from Surgeons Wanting to Learn StomaphyX(TM) Procedures
6. Veterinary Dentistry Opens Wide
7. Head Lice Removal Service Opens in Chicago
8. OHSU Cancer Institute research discovery opens new window to understanding chronic myeloid leukemia
9. Orbel Opens New Electroplating and Photo Chemical Milling Facility in Easton, PA
10. Navitas Opens Cancer Rehabilitation Center in Denver in Conjunction With Presbyterian / St. Lukes Medical Center
11. Kaiser Permanente Opens 15th Medical Facility in Georgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/26/2014)... 2014 Cooking and warming equipment ... of 5. This score reflects slightly positive negotiation conditions ... specialization, low switching costs and a low level of ... low availability of substitutes for cooking and warming equipment ... and aluminum, key inputs in the production process of ...
(Date:12/26/2014)... (PRWEB) December 26, 2014 “Many people ... with personal injury claim issues and phone calls with ... released an article featuring their free eBook on ... helpful eBook on pedestrian and bicycle auto accident claims ... is fully capable of professionally handling their case while ...
(Date:12/26/2014)... AZ (PRWEB) December 26, 2014 ... source for the best in heating, cooling and ... for 24 hour emergency services in 2014 with ... alike know that Arizona is known for its ... company that understands the intricacies and details of ...
(Date:12/25/2014)... 26, 2014 The report “Nintedanib ... 2023” focuses on the current treatment landscape, unmet ... colorectal cancer market. Stivarga is a drug which ... rectal cancer. Boehringer Ingelheim is developing nintedanib (BIBF-1120), ... of refractory CRC in the US, Europe, and ...
(Date:12/25/2014)... Recently, iFitDress.com, the popular online supplier of ... its new selection of black one-shoulder cocktail dresses . ... they are available at discounted prices, up to 70% off. ... last for three weeks only. You know, we have thousands ... interested in our new items can visit our website for ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Guide to Handling Pedestrian and Bicycle Accidents Released By The Jones Firm, Featured in Recent Article 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4Health News:iFitDress.com: Black One-Shoulder Cocktail Dresses for 2015 2
... HealthDay Reporter , MONDAY, Nov. 8 (HealthDay News) -- A ... drugs called statins do not reduce their risk for colorectal ... the risk of colorectal cancer. But this new study ... of the type of statin taken or for how long. ...
... November, 2010 Saints Medical Center is pleased ... hospitalist department, has received a patent for a lightweight plastic ... Stethguard is a V-shaped clear plastic cover that ... where most of the germs and bacteria are located. ...
... to restore retinal health in the eyes of diabetic mice has ... it might do the same for people. "We want to ... devastation that can occur with diabetes," said Dr. Sylvia Smith, retinal ... Medical College of Georgia. "That means we need to know more ...
... It is well known that oral infection progressively destroys ... loss in adults. A major goal of periodontal treatment ... most current therapies cannot predictably promote repair of tooth-supporting ... clinically using bone grafts and guiding tissue membranes with ...
... New research suggests that a newer drug works no better ... treatment for a type of vasculitis, a rare blood vessel ... kid on the block," said Dr. Ronald Falk, a kidney ... news because relapses and serious side effects are common over ...
... MONDAY, Nov. 8 (HealthDay News) -- A solar-powered blood-pressure measuring ... rates of cardiovascular disease in low-income nations, according to a ... Africa -- two in Uganda and one in Zambia -- ... agreement with the standard blood-pressure testing method for systolic blood ...
Cached Medicine News:Health News:Statins Don't Reduce Colon Cancer Risk, Study Finds 2Health News:Statins Don't Reduce Colon Cancer Risk, Study Finds 3Health News:Mass. doctor invents product to curb hospital-acquired infections 2Health News:Potential drug therapy for diabetic retinopathy under study 2Health News:Potential drug therapy for diabetic retinopathy under study 3Health News:Growth factor regenerates tooth supporting structures: Results of a large randomized clinical trial 2Health News:Cheaper, Older Treatment for Vasculitis Beats Out New Drug 2Health News:Solar Blood-Pressure Device Shows Promise for Use in Poor Nations 2
(Date:12/24/2014)... 2014  Medical Science Liaisons play a large role ... the medical device industry and key stakeholders, the role ... years as the device industry relies on them to ... by benchmarking firm, Best Practices, LLC, one area where ... is by harnessing new technology to enable education. Online ...
(Date:12/22/2014)... Mass. , Dec. 22, 2014 ... leading manufacturer of innovative dialysis products, announced today ... has cleared its System One™ to perform hemodialysis ... known as home nocturnal hemodialysis. NxStage,s® System One ... by the FDA for this indication. ...
(Date:12/22/2014)... , Dec. 22, 2014 Research and Markets ... of the "US Self-monitoring Blood Glucose Market" ... http://photos.prnewswire.com/prnh/20130307/600769 This market insight focuses on ... the United States . Reimbursement analysis ... Thorough product analyses for more than 73 SMBG meters ...
Breaking Medicine Technology:Role of Medical Science Liaisons Evolving in Medical Device Sector 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3US Self-monitoring Blood Glucose Market 2
... The ABI Prism 7000 Sequence ... PCR system that detects and quantitates ... cycle-by-cycle detection of accumulated PCR product ... cycling, fluorescence detection, and application-specific software ...
RIA kit for the determination of autoantibodies to the TSH receptor (TSHR) in serum [with calibrators]....
ELISA kit for the determination of autoantibodies to the TSH receptor (TSHR) in serum....
Coated-Tube (CT) RIA kit for the determination of autoantibodies to the TSH receptor (TSHR) in serum...
Medicine Products: